
Pfizer is a research based global biopharmaceutical company that engaged in the discovery, development & manufacturing of healthcare products that includes medicines and vaccines to improve patient’s lives.
It has been operating in Saudi Arabia since early 1960s. And it has a portfolio in different therapeutic areas include internal medicines, vaccines, oncology, inflammation & Immunology, rare diseases, hospital healthcare, cardiovascular that aim to provide high quality medicines, promoting health, raising awareness bar of various diseases and therapeutic areas, and providing a preventive solutions in partnership with the local government and private healthcare institutions.

Mundipharma is a global healthcare company committed to advancing therapies that address areas of significant clinical need.
Through rigorous research, strategic collaborations, and a sustained focus on patient outcomes, we deliver solutions that support healthcare professionals and strengthen standards of care.
Our antifungal portfolio includes REZZAYO® (rezafungin), a next-generation echinocandin developed to provide once-weekly dosing for adults with invasive candidiasis.
This innovation reflects our broader mission: to bring clinically meaningful advancements to complex therapeutic areas while fostering reliability, quality, and scientific excellence across the healthcare ecosystem.

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries






© Copyright IDIC 2025 - Infectious Disease in Immunocompromised Patients. All Rights Reserved.